Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-08

Clinical Trial Update: Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation [NA]

View source ↗

Summary

Abbott Medical Devices completed a clinical trial evaluating prevention of atrial fibrillation using optimized overdrive stimulation. The study involved conditi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Optimized Overdrive Stimulation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Bradycardia, Atrial Fibrillation | NA | Status: COMPLETED